These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Innovation of anti-inflammatory drugs--inhibition of cyclooxygenases]. Guo ZR Yao Xue Xue Bao; 2005 Nov; 40(11):967-9. PubMed ID: 16499077 [No Abstract] [Full Text] [Related]
3. The problem of new uses. Eisenberg RS Yale J Health Policy Law Ethics; 2005; 5(2):717-39. PubMed ID: 16052897 [No Abstract] [Full Text] [Related]
4. Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study. Rahme E; Nedjar H Rheumatology (Oxford); 2007 Mar; 46(3):435-8. PubMed ID: 17255138 [TBL] [Abstract][Full Text] [Related]
5. Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Hermann M; Ruschitzka F Intern Med J; 2006 May; 36(5):308-19. PubMed ID: 16650196 [TBL] [Abstract][Full Text] [Related]
6. [Effect of nonsteroidal anti-inflammatory agents on the cardiovascular system]. Stepaniuk GI; Stoliarchuk AA Farmakol Toksikol; 1987; 50(5):89-93. PubMed ID: 3319688 [No Abstract] [Full Text] [Related]
8. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs. Mitchell JA; Warner TD Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib shown effective in preventing colon polyps. Nelson NJ J Natl Cancer Inst; 2006 May; 98(10):665-7. PubMed ID: 16705118 [No Abstract] [Full Text] [Related]
10. Aspirin, NSAIDs, and cardiovascular risk: is there a link? Kapoor JR Am J Med; 2008 Nov; 121(11):e9. PubMed ID: 18954833 [No Abstract] [Full Text] [Related]
11. Cyclooxygenase-2 inhibitors: what went wrong? James MJ; Cleland LG Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):89-94. PubMed ID: 16477171 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Hermann M; Ruschitzka F Ann Med; 2007; 39(1):18-27. PubMed ID: 17364448 [TBL] [Abstract][Full Text] [Related]
13. What price pain relief? Hochman JS; Shah NR Circulation; 2006 Jun; 113(25):2868-70. PubMed ID: 16785335 [No Abstract] [Full Text] [Related]
14. The lipoxygenase-cyclooxygenase inhibitor licofelone prevents thromboxane A2-mediated cardiovascular derangement triggered by the inflammatory peptide fMLP in the rabbit. Rotondo S; Dell'Elba G; Manarini S; Cerletti C; Evangelista V Eur J Pharmacol; 2006 Sep; 546(1-3):95-101. PubMed ID: 16920097 [TBL] [Abstract][Full Text] [Related]
15. The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults. Wilson SL; Poulter NR J Hypertens; 2006 Aug; 24(8):1457-69. PubMed ID: 16877945 [TBL] [Abstract][Full Text] [Related]
16. [Combination therapy with acetylsalicylic acid and non-aspirin nonsteroidal anti-inflammatory drugs]. Reuther LØ; Andersen SE Ugeskr Laeger; 2006 Mar; 168(13):1310-4. PubMed ID: 16579883 [TBL] [Abstract][Full Text] [Related]
17. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Maree AO; Fitzgerald DJ Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618 [No Abstract] [Full Text] [Related]
18. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction. Jugdutt BI Circulation; 2007 Jan; 115(3):288-91. PubMed ID: 17242292 [No Abstract] [Full Text] [Related]
19. The pharmacology of selective inhibition of COX-2. Grosser T Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913 [TBL] [Abstract][Full Text] [Related]
20. [How to reduce the risks of NSAIDs]. Gross M MMW Fortschr Med; 2008 Jul; 150(28-31):50-3; quiz 54. PubMed ID: 19006892 [No Abstract] [Full Text] [Related] [Next] [New Search]